Cue Biopharma, Inc. (CUE)
23.16
-0.82
(-3.42%)
USD |
NASDAQ |
Aug 24, 16:00
23.16
0.00 (0.00%)
After-Hours: 20:00
Cue Biopharma Total Liabilities (Quarterly) : 28.40M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.40M |
| March 31, 2026 | 9.269M |
| December 31, 2025 | 16.71M |
| September 30, 2025 | 18.40M |
| June 30, 2025 | 22.55M |
| March 31, 2025 | 15.67M |
| December 31, 2024 | 14.69M |
| September 30, 2024 | 19.44M |
| June 30, 2024 | 20.71M |
| March 31, 2024 | 23.91M |
| December 31, 2023 | 24.44M |
| September 30, 2023 | 26.22M |
| June 30, 2023 | 27.16M |
| March 31, 2023 | 26.66M |
| December 31, 2022 | 25.60M |
| September 30, 2022 | 25.54M |
| June 30, 2022 | 24.99M |
| March 31, 2022 | 26.03M |
| Date | Value |
|---|---|
| December 31, 2021 | 17.91M |
| September 30, 2021 | 15.36M |
| June 30, 2021 | 16.76M |
| March 31, 2021 | 19.05M |
| December 31, 2020 | 20.62M |
| September 30, 2020 | 19.06M |
| June 30, 2020 | 21.20M |
| March 31, 2020 | 15.41M |
| December 31, 2019 | 17.02M |
| September 30, 2019 | 18.19M |
| June 30, 2019 | 21.48M |
| March 31, 2019 | 20.45M |
| December 31, 2018 | 11.39M |
| September 30, 2018 | 5.178M |
| June 30, 2018 | 3.882M |
| March 31, 2018 | 4.084M |
| December 31, 2017 | 5.347M |
| September 30, 2017 | 1.915M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 446.97M |
| Fortress Biotech, Inc. | 110.63M |
| Equillium, Inc. | 2.65M |
| Legend Biotech Corp. | 521.32M |
| Nurix Therapeutics, Inc. | 132.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 30.71M |
| Shareholders Equity (Quarterly) | 2.31M |
| Debt to Equity Ratio | 3.813 |
| Current Ratio | 1.255 |
| Net Debt Paydown Yield | -0.20% |